Antiplatelet therapies in ischemic stroke patients with diabetes mellitus or insulin resistance / 国际脑血管病杂志
International Journal of Cerebrovascular Diseases
;
(12): 930-935, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-507714
ABSTRACT
Diabetes mellitus is an independent predictor of high platelet reactivity after antiplatelet therapy in patients with ischemic stroke,and the latter is closely related to the increased risk of recurrence of stroke.The mechanisms of high platelet reactivity in patients with diabetes or insulin resistance are associated with a variety of factors.Some circulating molecules can be used as markers for predicting the reactivity of platelets.Monitoring of platelet reactivity after treatment with new antiplatelet agents may provide basis for individualized antithrombotic therapy in ischemic stroke patients with diabetes or insulin resistance.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio pronóstico
Idioma:
Chino
Revista:
International Journal of Cerebrovascular Diseases
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS